Visceral adiposity and incident coronary heart disease in Japanese- American men: The 10-year follow-up results of the Seattle Japanese-American community diabetes study

Diabetes Care

Volumn 22, Issue 11, 1999, Pages 1808-1812

  Fujimoto, Wilfred Y ^a   Bergstrom, Richard W ^a   Boyko, Edward J ^a   Chen, Kwang Wen ^a   Leonetti, Donna L ^a   Newell Morris, Laura ^a   Shofer, Jane B ^a   Wahl, Patricia W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DIABETES MELLITUS; ETHNIC GROUP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; OBESITY; RISK FACTOR;

ADIPOSE TISSUE; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; VISCERA; WASHINGTON;

EID: 0032759437     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.11.1808     Document Type: Article

References (58)

1. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
2. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
3. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
4. Krotkiewski M, Björntorp P, Sjöström L, Smith U: Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 72: 1150-1162, 1983
5. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149:1514-1520, 1989
6. Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, Gustafson AB, Kissebah AH: Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 110:867-872, 1989
7. Després J-P, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10:497-511, 1990
8. Bergstrom RW, Leonetti DL, Newell-Morris LL, Shuman WP, Wahl PW, Fujimoto WY: Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance. Diabetologia 33:489-496, 1990
9. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104-111, 1990
10. Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD: The visceral adiposity syndrome in Japanese-American men. Obesity Res 2:364-371, 1994
11. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G: Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13-year follow-up of participants in the study of men born in 1913. Br Med J 288:1401-1404, 1984
12. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261, 1984
13. Ducimeter P, Richard J, Cambien F: The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. Int J Obes 10:229-240, 1986
14. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K: Central obesity and coronary heart disease in men. Lancet i:822-824, 1987
15. Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris LL, Shuman WP, Stolov WC, Wahl PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36:721-729, 1987
16. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
17. Rose GA, Blackburn H: Cardiovascular Survey Methods. Geneva, World Health Organization, 1968, p. 137-141
18. Shuman WP, Newell-Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, Fujimoto WY: Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 21:483-487, 1986
19. Newell-Morris, LL, Treder RP, Shuman WP, Fujimoto WY: Fatness, fat distribution, and glucose tolerance in second-generation Japanese-American (Nisei) men. Am J Clin Nutr 50:9-18, 1989
20. Despres JP, Lemieux S, Lamarche B, Prud'homme D, Moorjani S, Brun LD, Gagne C, Lupien PJ: The insulin resistance dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Internat J Obes 19 (Suppl 1):S76-S86, 1995
21. Tchernof A, Lamarche B, Prud'homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Despres JP: The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19:629-637, 1996
22. Cigolini M, Targher G, Andreis IAB, Tonoli M, Agostino G, De Sandre G: Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 16:368-374, 1996
23. Lindahl B, Asplund K, Eliasson M, Evrin PE: Insulin resistance syndrome and fibrinolytic activity: the Northern Sweden MONICA Study. Internat J Epidemiol 25:291-299, 1996
24. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O: Plasma fibrinogen: a new factor of the metabolic syndrome: a population-based study. Diabetes Care 21: 649-654, 1998
25. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610, 1996
26. Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB Jr, Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF: Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Athersoclerosis Study. Diabetes 45:1547-1555, 1996
27. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE: Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96:1102-1108, 1997
28. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867, 1997
29. Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, Yoshizumi M, Toba K, Ouchi Y: The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Internal J Obes 22:477-484, 1998
30. Burchfiel CM, Curb JD, Arakaki R, Abbott RD, Sharp DS, Rodriguez BL, Yano K: Cardiovascular risk factors and hyperinsulinemia in elderly men: the Honolulu Heart Program. Ann Epidemiol 6:490-497, 1996
31. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett KC, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921, 1988
32. Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276:875-881, 1996
33. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 95:69-75, 1997
34. Pyörälä M, Miettinen H, Laakso M, Pyörälä K: Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 98: 398-404, 1998
35. Cullen K, Stenhouse NS, Wearne KL, Welborn TA: Multiple regression analyses of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: a 13-year study. J Chron Dis 36:371-377, 1983
36. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 34:356-361, 1991
37. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KGMM: Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol 144:224-234, 1996
38. Yarnell JWG, Sweetnam PM, Marks V, Teale TD, Bolton CH: Insulin in ischemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J 71:293-296, 1994
39. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
40. Boyko EJ, Leonetti DL, Bergstrom RW, Fujimoto WY: Fasting insulin level underestimates risk of non-insulin-dependent diabetes mellitus due to confounding by insulin secretion. Am J Epidemiol 145:18-23, 1997
41. Yip J, Facchini FS, Reaven GM: Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83:2773-2776, 1998
42. Fuller JH, Shipley MJ, Rose G: Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall Study. Lancet i: 1373-1376, 1980
43. Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschewege E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360-367, 1998
44. Meigs JB, Nathan DM, Wilson PWF, Cupples LA, Singer DE: Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham offspring study. Ann Intern Med 128:524-533, 1998
45. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program. Diabetes 36:689-692, 1987
46. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
47. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
48. Giugliano D, Ceriello A, Paolisso G: Diabetes mellitus, hypertension, and cardiovascular disease: the role of oxidative stress? Metabolism 44:363-368, 1995
49. Carter AM, Grant PJ: Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus. Diabet Med 14:423-432, 1997
50. Ostermann H, van de Loo J: Factors of the hemostatic system in diabetic patients. Hemostosis 16:386-416, 1986
51. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
52. Vlassara H: Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 124: 19-30, 1994
53. Sobel BE, Woodcock-Mitchell J, Schneider DJ, Holt RE, Marutsuka K, Gold H: Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence. Circulation 97:2213-2221, 1998
54. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA: Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695-1701, 1998
55. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Circulation 95:1783-1790, 1997
56. Patino R, Ibarra J, Molino A, Fernandez-Durango R, Moya J, Fernandez-Cruz A: Increased plasma endothelin in diabetes: an atherosclerosis marker? Diabetologia 37: 333-334, 1994
57. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, Omata M: Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 30:1472-1477, 1997
58. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Woo-Soo S, Nishikawa J, Sasaki Y, Omata M: Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 47:119-124, 1998